Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
3081
-
3082
-
3083
The Second Incisional Site Metastasis in a Patient with Cervical Carcinoma: A Case Report
Published 2013-12-01Get full text
Article -
3084
-
3085
-
3086
Expression of Tropomyosin 1 Gene Isoforms in Human Breast Cancer Cell Lines
Published 2015-01-01Get full text
Article -
3087
-
3088
-
3089
-
3090
-
3091
Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients
Published 2023-06-01Get full text
Article -
3092
-
3093
-
3094
-
3095
-
3096
-
3097
-
3098
Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity
Published 2025-01-01Get full text
Article -
3099
-
3100
Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysisResearch in context
Published 2025-03-01“…In real-world studies, the pooled median OS of ICIs were 11.8 months (95% CI: 11.2–12.4); Eastern Cooperative Oncology Group (EOCG) score, histological type, PD-L1 status, with immune-related adverse events (irAEs), and treatment mode were predictive for OS; rates of irAEs and discontinuation were numerically higher for combination therapy vs. monotherapy. …”
Get full text
Article